Nanobiotix S.A. reported its total number of shares outstanding and voting rights as of March 31, 2026, providing routine capital structure transparency to investors.
Key takeaways
The company had 48,517,630 shares outstanding as of March 31, 2026.
The total theoretical voting rights were 50,165,132, while exercisable voting rights were 50,143,014 as of March 31, 2026.
The disclosure is made in accordance with French Commercial Code and AMF regulations for shareholder transparency.
The company remains listed on Euronext Paris and Nasdaq Global Select Market.